The board of directors of AegirBio has now received the results of the internal investigation concerning the company’s distributor, which was carried out by external parties. As a consequence hereof, AegirBio terminates the distribution agreement with NowMed Sweden AB.

AegirBio is taking control over the company’s distribution in Asia until an agreement is signed with a new distributor. NowMed Sweden AB is working on transferring all purchase orders from the local distributor to AegirBio, including the purchase order that has already been sent to Thailand. AegirBio is now establishing a direct line of contact with the local distributor of the pre-existing purchase orders in Thailand to secure the volumes, destinations, call-offs on purchase orders and time of delivery. It is also Aegirbio’s intention to hire a regional consultant to further monitor the company’s interests in Asia.

AegirBio is also, with immediate effect, taking control of the current business in Sweden as well as the contact with potential customers in and outside of Sweden.

This press release was published yesterday. This is a translated version of the original press release in Swedish. The information was such information that AegirBio was obliged to make public pursuant to the EU Market Abuse Regulation. The information was released for public disclosure through the contact persons detailed below on 25 October 2021 at 22:15 CET.

es_ESES
Resumen de privacidad

Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.